BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16289380)

  • 1. Expression of 5-oxoETE receptor in prostate cancer cells: critical role in survival.
    Sundaram S; Ghosh J
    Biochem Biophys Res Commun; 2006 Jan; 339(1):93-8. PubMed ID: 16289380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase.
    Ghosh J
    Biochem Biophys Res Commun; 2004 Mar; 315(3):624-35. PubMed ID: 14975747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression.
    Pidgeon GP; Tang K; Cai YL; Piasentin E; Honn KV
    Cancer Res; 2003 Jul; 63(14):4258-67. PubMed ID: 12874035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OXER1, a G protein-coupled oxoeicosatetraenoid receptor, mediates the survival-promoting effects of arachidonate 5-lipoxygenase in prostate cancer cells.
    Sarveswaran S; Ghosh J
    Cancer Lett; 2013 Aug; 336(1):185-95. PubMed ID: 23643940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
    Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H
    Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D; Falany CN
    Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
    You Z; Shi XB; DuRaine G; Haudenschild D; Tepper CG; Lo SH; Gandour-Edwards R; de Vere White RW; Reddi AH
    Cancer Res; 2006 Jan; 66(1):175-83. PubMed ID: 16397230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
    Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC
    Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.
    Subbarayan V; Krieg P; Hsi LC; Kim J; Yang P; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
    Oncogene; 2006 Sep; 25(44):6015-25. PubMed ID: 16682954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase.
    Moretti RM; Montagnani Marelli M; Sala A; Motta M; Limonta P
    Int J Cancer; 2004 Oct; 112(1):87-93. PubMed ID: 15305379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
    Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
    Skvortsova I; Skvortsov S; Stasyk T; Raju U; Popper BA; Schiestl B; von Guggenberg E; Neher A; Bonn GK; Huber LA; Lukas P
    Proteomics; 2008 Nov; 8(21):4521-33. PubMed ID: 18821526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-lipoxygenase metabolites of gamma-linolenic acid/eicosapentaenoic acid suppress growth and arachidonic acid metabolism in human prostatic adenocarcinoma cells: possible implications of dietary fatty acids.
    Vang K; Ziboh VA
    Prostaglandins Leukot Essent Fatty Acids; 2005 May; 72(5):363-72. PubMed ID: 15850718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenase.
    McCabe NP; Selman SH; Jankun J
    Prostate; 2006 May; 66(7):779-87. PubMed ID: 16482570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
    Yu S; Wang X; Ng CF; Chen S; Chan FL
    Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.